SUSAN

Tokio Marine HCC – Specialty Group and Susan G. Komen® Pair Up With World No. 1 Golfer Nelly Korda to Help End Breast Cancer

Retrieved on: 
Tuesday, May 28, 2024
Insurance, Partnership, Patient, Tokio Marine, LED, Good Company, Disease, Breast cancer, Sport, Philosophy, Good, Attention, Culture, Woman, Golf, Pharmaceutical industry

WAKEFIELD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- As the biggest women’s U.S. golf tournament tees off, Susan G. Komen®, the world's leading breast cancer organization, is proud to partner with Tokio Marine HCC – Specialty Group (TMHCC), based in Wakefield, Massachusetts, a premier provider of specialized insurance products for the sports and entertainment industries, and Nelly Korda, the number one world ranked women’s golfer. This collaboration aims to support efforts to end breast cancer and bring vital resources to those affected by the disease during the premier women’s U.S. golf tournament, taking place from May 30 to June 2 in Lancaster, Pennsylvania.

Key Points: 
  • Campaign Led by Tokio Marine HCC – Specialty Group Aims to Improve and Save Lives Impacted by Breast Cancer as Susan G. Komen Works to Provide Access to High-Quality Breast Care and Services.
  • Every 12 minutes, a woman in the U.S. succumbs to breast cancer, a disease that disregards age, gender, socio-economic status or location.
  • Experts suggest one-third of U.S. breast cancer deaths could be preventable with universal access to modern treatments.
  • If Nelly achieves a career-best round, TMHCC will make an extraordinary donation of $1 million to Susan G. Komen.

Susan G. Komen® is MLB Together Beneficiary As Baseball Goes to Bat for Moms on Mother’s Day

Retrieved on: 
Friday, May 10, 2024
Sports, Professional Services, Health, Philanthropy, General Health, Women, Environmental, Social and Governance (ESG), Fund Raising, Foundation, Consumer, Baseball, Partnership, Club, Stand Up to Cancer, Statistics, Major League Baseball, Charitable organization, Mental health, Breast cancer, Research, League, Hat, Woman, MLB

This effort aligns closely with Susan G. Komen’s continued commitment to educating the public about the fundamentals of breast cancer.

Key Points: 
  • This effort aligns closely with Susan G. Komen’s continued commitment to educating the public about the fundamentals of breast cancer.
  • "When Komen joins forces with Major League Baseball on Mother’s Day, we celebrate moms for their unwavering dedication to others.
  • Teams across the League have partnered with Komen or another local health care organization to honor moms in MLB ballparks as part of MLB Together Mother’s Day program.
  • For more information on the various clubs holding in stadium events on game days, contact Cristobal Martinez at Susan G. Komen at [email protected] .

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing

Retrieved on: 
Thursday, May 2, 2024
Biotechnology, Professional Services, Health, General Health, Pharmaceutical, Other Science, Research, Genetics, Science, Clinical Trials, Finance, Doctor of Philosophy, CNS, SVP, Translational medicine, MIT, Genzyme, Cochlea, Hereditary Disease Foundation, Harvard Medical School, Toxicity, HTT, Therapy, Merck, CLN2, Hospital, Safety, Biomedical Research, Samsung Biologics, CHOP, Samsung C&T Corporation, AAV, Koch Institute, Gene expression, Central nervous system, NHP, Program management, Cell, DSM-IV codes, Patient, Gene, Society, Einstein Medical Center Philadelphia, Annual general meeting, Massachusetts General Hospital, Pharmaceutical industry

Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing.

Key Points: 
  • Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing.
  • These limitations have led to the reliance on high-dose injections that cause off-target toxicity and difficulties in scalable manufacturing.
  • The Company’s management team is composed of experienced and respected leaders in gene therapy and neuroscience.
  • Her address will showcase the Company's progress and the vast potential of its technology to solve unmet needs in CNS gene therapy.

National PKU Alliance Names Catherine Warren Executive Director

Retrieved on: 
Thursday, May 2, 2024
Volunteering, University, Outline of health sciences, National Multiple Sclerosis Society, MD, Research, Jefferson College, PKU, Metabolism, Pediatrics, Phenylketonuria, Growth, Connolly, Management

NEW YORK, May 2, 2024 /PRNewswire/ --The National PKU Alliance (NPKUA), whose mission is to improve the lives of people living with phenylketonuria (PKU) and pursue a cure, today announced Catherine Warren as the organization's new Executive Director.

Key Points: 
  • NEW YORK, May 2, 2024 /PRNewswire/ --The National PKU Alliance (NPKUA), whose mission is to improve the lives of people living with phenylketonuria (PKU) and pursue a cure, today announced Catherine Warren as the organization's new Executive Director.
  • Bringing nearly two decades of healthcare nonprofit development and management experience, Catherine served as Executive Director of the Susan G. Komen Virginia Blue Ridge Affiliate and later as Senior Director of Southwest Virginia for the Virginia Breast Cancer Foundation.
  • Catherine's personal connection to PKU began twelve years ago when her nephew was diagnosed at birth.
  • "I look forward to meeting more members of the PKU community at the bi-annual NPKUA conference this July 18-21, 2024 in Chantilly, Virginia."

Reimagine Care Unveils Expansion of Distinguished Clinical Advisory Board to Advance Virtual-first Cancer Care Innovation

Retrieved on: 
Tuesday, April 30, 2024
General Health, Health, Health Technology, Telemedicine, Virtual Medicine, Oncology, ION, EHR, Doctor of Philosophy, ASCO, Legislation, Medicine, Medical director, MHS, Knowledge, NCCS, Nursing, MPP, Informatics, Publication, Advisory board, Research, Public policy, Multimedia, Clinical trial, CTCA, Duke University Hospital, University, Cancer, Policy, EMR, Business development, MD, Duke, Patient, Doctor of Pharmacy, Society, Caregiver, Duke Cancer Institute

Reimagine Care, the nation’s leading provider of virtual-first cancer care, proudly announces the expansion of its esteemed Clinical Advisory Board with the appointment of renowned healthcare professionals with expertise in care across the cancer continuum.

Key Points: 
  • Reimagine Care, the nation’s leading provider of virtual-first cancer care, proudly announces the expansion of its esteemed Clinical Advisory Board with the appointment of renowned healthcare professionals with expertise in care across the cancer continuum.
  • Comprised of distinguished leaders, the board is poised to provide strategic guidance and insight to further enhance Reimagine Care's innovative solutions.
  • View the full release here: https://www.businesswire.com/news/home/20240430740623/en/
    Reimagine Care, the nation’s leading provider of virtual-first cancer care, proudly announces the expansion of its esteemed Clinical Advisory Board with the appointment of renowned healthcare professionals with expertise in care across the cancer continuum.
  • "We are delighted to welcome such a talented and acclaimed group of professionals to our Clinical Advisory Board," said Dan Nardi, CEO of Reimagine Care.

Susan G. Komen® Peoria MORE THAN PINK Walk Raises Funds for Breast Cancer Patient Care Services

Retrieved on: 
Monday, April 15, 2024
Research, Women, Philanthropy, Health, Fund Raising, Consumer, Foundation, Science, Oncology, Tears, Health equity, Par, Myriad Genetics, Laughter, Breast, Komatsu, Bank of America, Federation, Disease, Carle Foundation Hospital, Patient, Bank, MetroCentre, Breast cancer, Birth control

Susan G. Komen ®, the world’s leading breast cancer organization, will hold the Susan G. Komen Peoria MORE THAN PINK Walk on Saturday, May 11, 2024, at Metro Centre.

Key Points: 
  • Susan G. Komen ®, the world’s leading breast cancer organization, will hold the Susan G. Komen Peoria MORE THAN PINK Walk on Saturday, May 11, 2024, at Metro Centre.
  • This signature event enables Komen to raise critical funds that provide direct support to breast cancer patients, fund groundbreaking research, empower health equity initiatives nationwide, and advocate for change at both the state and federal government levels.
  • “We are excited to host the annual Peoria MORE THAN PINK Walk this year and provide a community for all individuals impacted by breast cancer.
  • Register today and join us as we celebrate survivors and those living with breast cancer as well as honor loved ones lost to the disease.

Susan G. Komen® Hosts MORE THAN PINK Walks in Philadelphia and Pittsburgh to Raise Money for Breast Cancer Research and Patients

Retrieved on: 
Wednesday, April 10, 2024
Other Consumer, Health, Philanthropy, General Health, Women, Oncology, Other Philanthropy, Family, Fund Raising, Foundation, Consumer, THAN, Disease, Caregiver, Woman, Breast, Patient, Research, Breast cancer

Susan G. Komen ®, the world’s leading breast cancer organization, will hold two MORE THAN PINK Walks in Pennsylvania this Spring to raise critical funds to advance Komen’s mission and provide support to people facing breast cancer now.

Key Points: 
  • Susan G. Komen ®, the world’s leading breast cancer organization, will hold two MORE THAN PINK Walks in Pennsylvania this Spring to raise critical funds to advance Komen’s mission and provide support to people facing breast cancer now.
  • The 2024 Philadelphia MORE THAN PINK Walk will take place on Mother’s Day, Sunday, May 12, and the 2024 Pittsburgh MORE THAN PINK Walk will take place on Sunday, May 19.
  • “Susan G. Komen is excited and honored to bring together communities across Pennsylvania at MORE THAN PINK Walks to pay tribute to and support those who have been impacted by this disease," said Brandie Engelberger, Executive Director of Pennsylvania at Susan G. Komen.
  • The Komen Patient Care Center can help meet the needs of anyone impacted by breast cancer.

Statement on Increased Funding Proposal for the New York State Cancer Services Program

Retrieved on: 
Thursday, March 28, 2024
Diagnosis, Control, Assembly, Breast, Cancer, State Assembly, New Yorker, Breast cancer, Health Bureau (Macau), CSP, Birth control

ALBANY, N.Y., March 28, 2024 /PRNewswire/ -- Susan G. Komen ®, the world's leading breast cancer organization commends the State Assembly's proposed funding increase of $2.5 million for the Cancer Services Program (CSP) in the FY2025 Budget.

Key Points: 
  • ALBANY, N.Y., March 28, 2024 /PRNewswire/ -- Susan G. Komen ®, the world's leading breast cancer organization commends the State Assembly's proposed funding increase of $2.5 million for the Cancer Services Program (CSP) in the FY2025 Budget.
  • "Komen commends the New York State Assembly for investing in the wellbeing of New Yorkers and securing funding for this critical program, supporting the state's vital healthcare infrastructure."
  • If an individual is found to have cancer, CSP will navigate the individual to the NYS Medicaid Cancer Treatment Program.
  • Thank you, Susan G. Komen Breast Cancer Foundation, for your advocacy supporting CSP and to eradicate breast cancer as a life-threatening disease."

Bill Introduced in Minnesota Would Increase Access To Genetic Testing

Retrieved on: 
Thursday, March 28, 2024
Mutation, Genetic testing, Breast, Disease, Risk, Patient, Cancer, HF, Woman, Saliva, Breast cancer, Collection, Blood, Legislation

ST. PAUL, Minn., March 28, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, applauds Representative Patty Acomb (D-Minnetonka) for introducing legislation that would eliminate financial barriers to clinically appropriate genetic testing, as well as the recommended screenings based on the results of that testing.

Key Points: 
  • In Minnesota, more than 5,480 people will be diagnosed with breast cancer and 630 are expected to die of the disease in 2024 alone.
  • In the U.S., 5-10% of breast cancers are related to a known inherited gene mutation.
  • HF 5050 , introduced by Rep Acomb, eliminates the patient out-of-pocket costs for multi-gene panel testing for inherited gene mutations and evidence-based screenings, ensuring individuals have access to critical information regarding their lifetime cancer risk and recommended early detection and cancer surveillance.
  • Germline testing is a type of test that looks for inherited mutations that have been present in every cell of the body since birth.

UCI Health celebrates transformational acquisition of four community hospitals

Retrieved on: 
Wednesday, March 27, 2024
University of California, Irvine, Health, Bed, Patient, Education, Public, UC, Hospital, Acquisition, University, Cancer, Doctor of Philosophy, Outline of health sciences, Tenet Healthcare, Eleutherios, FAAP, College of Health Sciences, Safety, Nursing care plan, Physician, Health Affairs, Nursing

ORANGE, Calif., March 27, 2024 /PRNewswire/ -- UCI Health, the clinical enterprise of the University of California, Irvine, has completed the acquisition of four hospitals and associated outpatient locations from Tenet Healthcare Corporation. Beginning today, the team members at Fountain Valley Regional Hospital, Lakewood Regional Medical Center Los Alamitos Medical Center and Placentia-Linda Hospital are now part of UCI Health.

Key Points: 
  • We celebrate the transformation of UCI Health as a leader in the integration of academic and community-based health systems while promoting solutions to challenges facing healthcare," said UC Irvine Chancellor Howard Gillman.
  • As Orange County's only academic health system, UCI Health plays a unique and critical role providing healthcare in the region.
  • "UCI Health has built a legacy as a nationally regarded academic health system that is fiercely dedicated to improving the health of our communities.
  • Lefteris said UCI Health recognizes a unique opportunity to build on the quality care already being delivered in the communities served by these hospitals.